Clinical Trials Browser

Phase 2 × Recurrent Uterine Sarcoma × Sorafenib × Clear all

NCT00238121 2015-11-20

Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer

Phase 2 Completed

56 enrolled 11 charts

GynecologicSarcoma

Recurrent Uterine Sarcoma